Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Annexin Pharmaceuticals AB

ANNX
Current price
0.57 SEK +0.016 SEK (+2.88%)
Last closed 0.56 SEK
ISIN SE0009664154
Sector Healthcare
Industry Biotechnology
Exchange Stockholm Exchange
Capitalization 263 213 563 SEK
Yield for 12 month -21.86 %
1Y
3Y
5Y
10Y
15Y
ANNX
21.11.2021 - 28.11.2021

Annexin Pharmaceuticals AB (publ), a biotechnology company, develops drug candidates for the treatment of various cardiovascular diseases. It develops ANXV, a human recombinant protein. The company offers Annexin A5 to protect and repair blood vessels and counteract inflammation. Annexin Pharmaceuticals AB (publ) was founded in 2014 and is based in Stockholm, Sweden. Address: Kammakargatan 48, Stockholm, Sweden, 111 60

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

11.41 SEK

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

-192 164 SEK

Last Year

-192 164 SEK

Current Quarter

Last Quarter

-47 794 SEK

Key Figures ANNX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -51 944 235 SEK
Operating Margin TTM
PE Ratio
Return On Assets TTM -101.63 %
PEG Ratio
Return On Equity TTM -220.41 %
Wall Street Target Price 11.41 SEK
Revenue TTM
Book Value 0.068 SEK
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share -0.19 SEK
Diluted Eps TTM -0.19 SEK
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics ANNX

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History ANNX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation ANNX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA -3.0132
Price Book MRQ 6.8329

Financials ANNX

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators ANNX

For 52 weeks

0.2 SEK 0.93 SEK
50 Day MA 0.68 SEK
Shares Short Prior Month
200 Day MA 0.4 SEK
Short Ratio
Shares Short
Short Percent